Skip to content
Innovative Tech
Diseases
Health Policy
HTA
Data Analysis
Clinical Practice
Contributors
BACK TO MAIN SITE
Cost Savings on Generic Drugs: Transparent Pric...
By
HEOR Staff Writer
June 18, 2024
Introduction Through its transparent, online direct-to-consumer pharmacy model, the Mark Cuban Cost Plus Drug Company (MCCPDC) has made substantial progress in the provisi...
Introducing GRACE for Patient-Centric Care
Universal Early Parenting Programmes: Unraveling the Cost-Effectiveness
Rethinking Health State Valuation: Moving Beyond ‘Dead’ as an Anchor
Europe MedTech Sector: Opportunities and Challenges
The Impact of Time Horizons on QALY Calculations in Healthcare
Making Better Choices in Diabetes Care With Multi-criteria Decision Making (M...
Unveiling the Future of Personalised Sleep Medicine
Nurturing Trust in Healthcare: Embracing Generative AI
The Power of Real-World Evidence: Bringing Everyday Health Data to Drug Appro...
Prevention is Better Than Cure: The Costs of the Pandemic Accord
Precision Medicine Competency Framework for the Medical Technology and Pharma...
Health equity insights for National Cancer Survivors Day
« Previous
1
…
25
26
27
28
29
…
52
Next »